Sitagliptin Intermediate 2

CAS No. 762240-92-6

Sitagliptin Intermediate 2( —— )

Catalog No. M35297 CAS No. 762240-92-6

Sitagliptin Intermediate 2 is a useful organic compound that has been used in life science related research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1G 26 Get Quote

Biological Information

  • Product Name
    Sitagliptin Intermediate 2
  • Note
    Research use only, not for human use.
  • Brief Description
    Sitagliptin Intermediate 2 is a useful organic compound that has been used in life science related research.
  • Description
    3-Trifluoromethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine (hydrochloride) is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    762240-92-6
  • Formula Weight
    228.603
  • Molecular Formula
    C6H8ClF3N4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (437.45 mM; Ultrasonic )
  • SMILES
    Cl.FC(F)(F)c1nnc2CNCCn12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • alpha-Viniferin

    α-Viniferin belongs to a class of organic compounds, also known as 2-arylbenzofuran flavonoids, that are inhibitors of prostaglandin H2 synthetase. α-Viniferin has anti-Alzheimer's disease, anti-tuberculosis, anti-tumor, anti-inflammation, anti-diabetes and other pharmacological activitie.

  • Palmitic acid

    Extracted from Palm tree fruit;Store the product in sealed, cool and dry condition.

  • Opnurasib

    Opnurasib (JDQ-443) is an orally available and selective and potent covalent KRAS G12C inhibitor with antitumor activity for the study of advanced non-small cell lung cancer.